Home>Healthcare>Pharmaceutical R&D

Pharmaceutical R&D

Fosun Pharma takes innovation and R&D as its core driving factor. Through independent R&D, cooperative development, license introduction and in-depth incubation, the Group has built and formed small molecule innovative drugs, antibody drugs and cell therapy technology platforms around centering on tumor and immune modulation, four hypers (hypertension, hyperlipidemia, hyperglycemia and hyperuricemia) and their complications, central nervous system and other major therapeutic areas, and actively explored cutting-edge technology fields such as Protac, RNA, oncolytic viruses and gene therapy to enhance its innovation capabilities.

Subsidiaries

About other business of Fosun Pharma